Find information on thousands of medical conditions and prescription drugs.

Suprefact

Buserelin is a gonadotropin releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.

It is normally delivered via a nasal spray but is also available as an injection.

Buserelin acetate is marketed by Sanofi-Aventis under the brand name Suprefact.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

Sodium cyclamate

Sulfamethoxazole

Suxamethonium chloride

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	Research and Markets: the Endometriosis Market is Expected to Change Dramatically Following the Patent Expiry of Key Brands Lupron Depot, Zoladex and Suprefact DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com) has announced the addition of Pipeline Insight: Endometriosis - Growing the Patient Population is Key to Unlocking the Ma From Business Wire, 9/27/04

	Comparison of Chemical-Activated Luciferase Gene Expression Bioassay and Gas Chromatography for PCB Determination in Human Serum and Follicular Fluid We assessed exposure to dioxin-like compounds using chemical and bioassay analysis in different matrices in a female population. A total of 106 serum ... From Environmental Health Perspectives, 6/1/00 by An Pauwels

	Buserelin Definition Buserelin is a synthetic analog of natural gonadotropin-releasing hormone and is used to treat prostate cancer. Buserelin, also ... From Gale Encyclopedia of Cancer, by M.S. Crystal Heather Kaczkowski

	Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients Two women, aged 44 and 29 years, respectively, were admitted to the hospital in early 1987 for recurrent pneumothorax, dyspnea and a diffuse reticulonodular ... From CHEST, 6/1/92 by Marc Radermecker

Home

Contact

Resources

ebay